Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Bay State Times.
Press releases published on June 10, 2025
MACOM IMS 2025 Product Preview – Electronic Countermeasures
GlobeNewswire
·
June 10, 2025
LOWELL, Mass., June 10, 2025 (GLOBE NEWSWIRE) -- MACOM Technology Solutions Inc. (“MACOM”), a leading supplier of semiconductor products, today announced availability of a wideband front end module (FEM) covering 2 to 18 GHz. Ideal for electronic …
Rose Hill Life Sciences to Spotlight Leading Research Partners at Psychedelic Science 2025
GlobeNewswire
·
June 10, 2025
Dr. Gül Dölen, MD, PhD, to share groundbreaking research on how psychedelic compounds can reopen “critical periods” of brain plasticity. Rotem Petranker, PhD, to discuss the latest findings from controlled clinical trials investigating the effects of …
Lantheus to Present at the 2025 Truist Securities MedTech Conference
GlobeNewswire
·
June 10, 2025
BEDFORD, Mass., June 10, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, …
Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 17, 2025
GlobeNewswire
·
June 10, 2025
CAMBRIDGE, Mass., June 10, 2025 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Company will participate in a fireside chat at the Truist …
Agilitas Energy Commissions Energy Storage System in Houston
GlobeNewswire
·
June 10, 2025
WAKEFIELD, Mass., June 10, 2025 (GLOBE NEWSWIRE) -- Agilitas Energy, a leading developer and operator of renewable energy and energy storage systems, today announced the commissioning of a 9.96 megawatt (MW) / 22.4 megawatt-hour (MWh) battery energy …
CervoMed Announces New Hire to Support Neflamapimod Development and Commercialization
GlobeNewswire
·
June 10, 2025
Strengthening CMC leadership to prepare for scaled up neflamapimod manufacturing On track to initiate Phase 3 trial of neflamapimod in DLB in mid-2026 following meeting with regulatory authorities BOSTON, June 10, 2025 (GLOBE NEWSWIRE) -- CervoMed Inc. ( …
X4 Pharmaceuticals Granted Fast Track Designation for Mavorixafor for the Treatment of Chronic Neutropenia by U.S. FDA
GlobeNewswire
·
June 10, 2025
BOSTON, June 10, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track …
Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference
GlobeNewswire
·
June 10, 2025
LEXINGTON, Mass., June 10, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today announced Alfred W. Sandrock, Jr., M.D., Ph.D., Chief Executive …
Monte Rosa Therapeutics Announces FDA Clearance of IND Application for MRT-8102, a NEK7-Directed Molecular Glue Degrader for the Treatment of Multiple Inflammatory Diseases
GlobeNewswire
·
June 10, 2025
MRT-8102, a highly selective NEK7-directed molecular glue degrader (MGD) developed to treat inflammatory conditions linked to NLRP3, IL-1β, and IL-6 dysregulation, expands Monte Rosa’s clinical I…
Molecular Partners Announces Planned Operational Efficiencies and Extension of Cash Runway
GlobeNewswire
·
June 10, 2025
Guidance confirmed for clinical milestones for MP0533 and MP0712 in H2 2025 Cash reach now anticipated to extend into 2028 ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., June 10, 2025 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR …